- Forums
- ASX - By Stock
- NEU
- Ann: Rett Syndrome NDA accepted for Priority Review by FDA
Ann: Rett Syndrome NDA accepted for Priority Review by FDA, page-36
-
- There are more pages in this discussion • 128 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$17.03 |
Change
0.700(4.29%) |
Mkt cap ! $2.139B |
Open | High | Low | Value | Volume |
$16.49 | $17.21 | $16.44 | $11.40M | 677.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4624 | $17.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.03 | 955 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 963 | 17.990 |
8 | 23975 | 17.980 |
1 | 408 | 17.900 |
1 | 706 | 17.830 |
2 | 881 | 17.760 |
Price($) | Vol. | No. |
---|---|---|
15.420 | 982 | 4 |
16.110 | 51 | 1 |
16.270 | 17184 | 9 |
16.280 | 5432 | 11 |
16.490 | 1796 | 2 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, MD & CEO
Charles Armstrong
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online